X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (611) 611
Publication (80) 80
Patent (19) 19
Book / eBook (6) 6
Book Chapter (4) 4
Web Resource (4) 4
Book Review (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (361) 361
middle aged (233) 233
aged (206) 206
adult (204) 204
hematology (202) 202
oncology (186) 186
female (180) 180
male (180) 180
index medicus (122) 122
leukemia, myeloid, acute - drug therapy (116) 116
antineoplastic combined chemotherapy protocols - therapeutic use (110) 110
prognosis (110) 110
treatment outcome (98) 98
aged, 80 and over (97) 97
remission induction (96) 96
adolescent (95) 95
acute myelogenous leukemia (82) 82
acute myeloid-leukemia (78) 78
acute myeloid leukemia (77) 77
leukemia, myeloid, acute - mortality (77) 77
cytarabine - administration & dosage (72) 72
acute disease (68) 68
cancer (61) 61
therapy (57) 57
survival analysis (55) 55
aml (53) 53
antineoplastic agents - therapeutic use (53) 53
antineoplastic combined chemotherapy protocols - adverse effects (53) 53
chemotherapy (53) 53
survival rate (51) 51
leukemia (49) 49
leukemia, myeloid, acute - genetics (49) 49
recurrence (47) 47
article (45) 45
myelodysplastic syndrome (43) 43
myelodysplastic syndromes - drug therapy (41) 41
disease-free survival (39) 39
leukemia, myeloid, acute - therapy (38) 38
retrospective studies (38) 38
survival (38) 38
leukemia, myeloid - drug therapy (37) 37
research (37) 37
leukemia, myeloid, acute - diagnosis (36) 36
leukemia, myeloid, acute - pathology (36) 36
myelodysplastic syndromes (36) 36
young adult (36) 36
cytarabine (34) 34
time factors (31) 31
drug administration schedule (30) 30
dose-response relationship, drug (28) 28
vidarabine - analogs & derivatives (28) 28
risk factors (27) 27
age factors (26) 26
cells (26) 26
cytarabine - adverse effects (26) 26
myelodysplastic syndromes - mortality (26) 26
multivariate analysis (25) 25
antineoplastic combined chemotherapy protocols - administration & dosage (24) 24
cytogenetics (24) 24
follow-up studies (24) 24
gemtuzumab ozogamicin (24) 24
adults (23) 23
care and treatment (23) 23
abridged index medicus (22) 22
acute lymphoblastic-leukemia (22) 22
hematopoietic stem cell transplantation (22) 22
idarubicin - administration & dosage (22) 22
karyotyping (22) 22
relapse (22) 22
vidarabine - administration & dosage (22) 22
acute promyelocytic leukemia (21) 21
expression (21) 21
hemic and lymphatic diseases (21) 21
myelodysplastic syndromes - pathology (21) 21
complete remission (20) 20
leukemia, myeloid, acute - metabolism (20) 20
acute leukemia (19) 19
chronic lymphocytic-leukemia (19) 19
colony-stimulating factor (19) 19
cytarabine - therapeutic use (19) 19
hematology, oncology and palliative medicine (19) 19
induction chemotherapy (19) 19
leukemia, myeloid - mortality (19) 19
antibodies, monoclonal, humanized (18) 18
antineoplastic agents - adverse effects (18) 18
diagnosis (18) 18
health aspects (18) 18
infusions, intravenous (18) 18
myelodysplastic syndromes - genetics (18) 18
remission (18) 18
transplantation (18) 18
child (17) 17
daunorubicin - administration & dosage (17) 17
induction therapy (17) 17
leukemia - drug therapy (17) 17
leukemia, promyelocytic, acute - drug therapy (17) 17
drug therapy (16) 16
myeloid leukemia (16) 16
older patients (16) 16
proportional hazards models (16) 16
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2008, Hematologic malignancies, ISBN 3540723021, x, 294
Better therapy of acute leukemias depends ultimately on better understanding of the distinction between leukemic and normal progenitor cells. Thus, several... 
Acute leukemia -- Treatment | Acute leukemia | Clinical & internal medicine
Book
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 718 - 718
Abstract Background: Treatment of acute myeloid leukemia (AML) remains a significant challenge: induction chemotherapy is associated with substantial... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2012, Volume 30, Issue 2, pp. 219 - 220
Journal Article
Current Opinion in Hematology, ISSN 1065-6251, 03/2019, Volume 26, Issue 2, pp. 65 - 70
PURPOSE OF REVIEWPatients with acute myeloid leukemia (AML) are almost invariably kept in the hospital until resolution of cytopenias following intensive... 
cost-effectiveness | outpatient care | ANTICANCER MEDICATIONS | ECONOMIC BURDEN | TREATMENT-NAIVE | acute myeloid leukemia | DOSE CYTARABINE | TREATMENT PATTERNS | early hospital discharge | QUALITY-OF-LIFE | GREATER-THAN-OR-EQUAL-TO-65 YEARS | resource utilization | STEM-CELL TRANSPLANTATION | HEMATOLOGY | INTENSIVE INDUCTION | Chemotherapy | Usage | Cancer
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 2602 - 2602
Abstract Introduction: Cytogenetic analyses are critical in the management of a variety of malignancies. In acute myeloid leukemia (AML), tumor karyotype is... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1513 - 1513
Abstract Introduction. The E-selectin ligand is a carbohydrate structure (sialyl Lewis x) expressed on myeloid cells and plays a role in cell adhesion and... 
Journal Article
American Journal of Hematology, ISSN 0361-8609, 11/2014, Volume 89, Issue 11, pp. 1063 - 1081
Journal Article